Related Experiment Video
Updated: Jan 13, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Trends In Biopharmaceutical Clinical Trials After Medicare Drug Price Negotiation
So-Yeon Kang1, Mingqian Liu2, Yunan Ji3
1So-Yeon Kang, Georgetown University, Washington, D.C.
Abstract:
The Inflation Reduction Act of 2022 authorized Medicare to negotiate prices for selected drugs, with implications for innovation. Using ClinicalTrials.gov data on biopharmaceutical trials initiated during 2015-24, we found that overall trial activity remained stable, returning to prepandemic levels, but manufacturers with drugs subject to negotiation initiated fewer trials, particularly in certain cancers.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

